Navigation Links
Stryker Announces Additional $500 Million Share Repurchase Program and Declares a 20% Increase in Quarterly Dividend
Date:12/8/2010

KALAMAZOO, Mich., Dec. 8, 2010 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE: SYK) announced today that its Board of Directors has increased its dividend by 20% by declaring a quarterly dividend of $0.18 per share payable on January 31, 2011, to shareholders of record at the close of business on December 31, 2010.  

Stryker also announced today that its Board of Directors has authorized the Company to repurchase an additional $500 million of its common stock.  The manner, timing and amount of any purchases will be determined by the Company's management based on their evaluation of market conditions, stock price and other factors and will be subject to regulatory considerations.  Purchases may be made from time to time in the open market, in privately negotiated transactions or otherwise.  

The strength of Stryker's balance sheet and considerable cash flow allow for the return of significant value to shareholders through both dividends and share repurchases while simultaneously making the necessary investments that will drive continued sales and earnings growth. Since the start of 2010, Stryker has returned approximately $238 million to shareholders through dividends. In addition, under the existing $750 million share repurchase program, the Company has repurchased approximately $410 million as of December 7, 2010, of which approximately $300 million was purchased since the beginning of the fourth quarter.

"Our strong performance in 2010 has allowed us to both meaningfully boost our R&D spending, while also continuing our pattern over the last few years of consistently and significantly increasing our dividend," said Stephen P. MacMillan, Chairman, President and Chief Executive Officer of Stryker. "The 20% dividend increase, coupled with the additional share repurchase authorization resulting from our strong cash flow generation, positions us well to continue to increase shareholder value."

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care.  The Company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives.  For more information about Stryker, please visit www.stryker.com.


'/>"/>
SOURCE Stryker Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
2. Medtronic, Stryker, and BrainLAB Covered in New Surgical Navigation Market Research Reports Released by Millennium Research Group
3. Stryker Announces Acquisition of Privately-Held Porex Surgical
4. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
5. Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010
6. Stryker to Host Conference Call on October 19, 2010
7. Stryker to Present at Investor Conference
8. Stryker to Host Conference Call on July 20, 2010
9. Stryker Declares a $0.15 Per Share Quarterly Dividend
10. Stryker Facilities Earn LEED® Certifications
11. Stryker Enters Strategic Marketing Agreement with Acuitec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , May 25, 2017  In response to ... , Direct Relief is working with Pfizer to ... available at no cost to community health centers, free ... providers nationwide. "Pfizer has a long-standing ... medicines and ensuring patient safety through educational activities," said ...
(Date:5/22/2017)... 2017  Lilac Corp, the company that sells ... of a new website . The website ... clinical study that showed surprising clearance of the ... individuals suffering from HPV warts, precancerous, or cancerous ... no other treatments that clear the virus. Specifically, ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... , ... “When the Stars Lead Home”: a poignant story of loss, determination, ... Weigel Douglas, an avid reader who lives in the Pacific Northwest with her husband, ... Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year old Tizzy could not ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... recipient of proceeds from its 14th Annual Clays for Kids fundraiser, to be ... 30, Bennett, Colorado. , As part of BluSky’s partnership with The Adoption ...
(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and ... Odds” is the creation of published author, Walter Hubbard, a retired wildlife and fisheries ... child Jane. Walter. Walter and Jane have three adult children and a granddaughter. ...
(Date:5/24/2017)... BELLEVILLE, N.J. (PRWEB) , ... May 24, 2017 ... ... joined Clara Maass Medical Center CEO Mary Ellen, hospital employees, and town officials ... in Belleville. , The facility was developed by Rendina as part of its ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD ... New York City. He is known for his distinguished expertise and experience in the ... Benvenisty holds sub-specialty training in treating renovascular disease and aortic aneurysm . He ...
Breaking Medicine News(10 mins):